stars 1 stars 2 stars 3

Sofinnova Investments is a healthcare investment firm committed to funding innovative products that aspire to meaningfully impact the lives of patients. We invest in both private and public equity companies. Sofinnova actively partners with entrepreneurs across all stages of company formation, we are long-term investors with extensive scientific expertise, vast industry knowledge, and a track record of helping forge the path from drug development and navigating the regulatory process to company building and IPO or M&A. Founded in 1976, Sofinnova has a long legacy of building what we believe are great companies in both the U.S. and Europe with approximately $4.6B in assets under management and committed capital as of 3/31/2026.

Sofinnova Investments Questions

The Sofinnova Investments annual revenue was $9.3 million in 2026.

Debbie Murray is the Chief People Officer of Sofinnova Investments.

40 people are employed at Sofinnova Investments.

Sofinnova Investments is based in Menlo Park, California.

The NAICS codes for Sofinnova Investments are [3254, 32541, 518, 325, 32, 51].

The SIC codes for Sofinnova Investments are [737, 283, 28, 73].

Top Sofinnova Investments Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users